Therapy of Steroid-Refractory Chronic GVHD with Subcutaneous Low-Dose Alemtuzumab and Rituximab Combination Is Effective and Safe

Saved in:
Bibliographic Details
Title: Therapy of Steroid-Refractory Chronic GVHD with Subcutaneous Low-Dose Alemtuzumab and Rituximab Combination Is Effective and Safe
Authors: Gutierrez-Aguirre, C.H.1, Cantu-Rodriguez, O.G.1, Gonzalez-Llano, O.1, Jaime-Perez, J.C.1, Mancias-Guerra, C.1, Flores-Jimenez, J.A.1, Alatorre-Ricardo, J.1, Gomez-Almaguer, D.1
Source: Biology of Blood & Marrow Transplantation. Feb2012 Supplement, Vol. 18 Issue 2, pS366-S366. 1p.
Database: Academic Search Ultimate
Description
ISSN:10838791
DOI:10.1016/j.bbmt.2011.12.432